Holen Sie sich die Stockscreener-App
0.9959
0.41%
-0.0041
Schlusskurs vom Vortag:
$1.00
Offen:
$0.9997
24-Stunden-Volumen:
330.28K
Relative Volume:
0.48
Marktkapitalisierung:
$96.77M
Einnahmen:
$11.03M
Nettoeinkommen (Verlust:
$-44.24M
KGV:
-1.6063
EPS:
-0.62
Netto-Cashflow:
$-42.61M
1W Leistung:
-7.79%
1M Leistung:
-9.46%
6M Leistung:
+34.36%
1J Leistung:
-1.40%
1-Tages-Spanne:
$0.97
$1.02
1-Wochen-Bereich:
$0.97
$1.09
52-Wochen-Spanne:
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Firmenname
Hyperfine Inc
Sektor
Branche
Telefon
866-796-6767
Adresse
351 NEW WHITFIELD STREET, GUILFORD
Vergleichen Sie HYPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.9959 | 97.17M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2022-04-14 | Eingeleitet | Wells Fargo | Overweight |
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Risk Check: Can Hyperfine Inc stock maintain growth trajectoryTrade Signal Summary & Comprehensive Market Scan Insights - moha.gov.vn
Hyperfine (HYPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Hyperfine Inc. stock a buy in volatile markets2025 Retail Activity & Low Risk High Win Rate Stock Picks - moha.gov.vn
How Hyperfine Inc. stock valuations compare to rivalsShort Setup & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Hyperfine receives $3.7M Gates Foundation grant - MSN
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - BioSpace
Is Hyperfine Inc. stock gaining market shareAnalyst Downgrade & Community Consensus Stock Picks - newser.com
Why Hyperfine Inc. stock could benefit from AI revolutionQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Teisseyre, Hyperfine COO, sells $1.5k in HYPR stock By Investing.com - Investing.com Canada
Real time pattern detection on Hyperfine Inc. stockJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Is Hyperfine Inc. stock a top momentum playWeekly Risk Summary & Precise Buy Zone Tips - newser.com
What catalysts could drive Hyperfine Inc. stock higherWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Teisseyre, Hyperfine COO, sells $1.5k in HYPR stock - Investing.com India
Hyperfine receives $3.7m Gates grant for AI-powered portable MRI - Investing.com Nigeria
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health - Lelezard
Hyperfine awarded $3.7M grant to advance global brain health - Hartford Business Journal
Why Hyperfine Inc. stock appeals to dividend seekersJuly 2025 Retail & Consistent Profit Trade Alerts - newser.com
Hyperfine receives $3.7m Gates grant for AI-powered portable MRI By Investing.com - Investing.com South Africa
What’s next for Hyperfine Inc. stock priceNew Guidance & Intraday High Probability Alerts - newser.com
Published on: 2025-11-19 04:32:29 - newser.com
B. Riley Adjusts Hyperfine Price Target to $1.30 From $1.40, Maintains Buy Rating - MarketScreener
Published on: 2025-11-16 14:30:33 - newser.com
Has Hyperfine Inc. formed a bullish divergence2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Hyperfine Inc. Reports Promising Growth in Latest Earnings Call - MSN
Hyperfine outlines $5M-$6M Q4 revenue target and accelerated growth following next-gen system launch - MSN
Hyperfine reports net loss of USD 11M in Q3 2025 - Medical Buyer
Hyperfine Ups The Pace With Fresh Cash And Rising Sales - Finimize
Finanzdaten der Hyperfine Inc-Aktie (HYPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):